Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-468-9 | CAS number: 121-43-7
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Formally, the REACH Annex XI standard testing regime adaptation options of 1.5 – Grouping of substances and read-across approach and 2. – Testing technically not possible, apply to trimethyl borate: As the borate will not exist in an organism for longer than one second, it is technically not possible to test its effects. Additionally, REACH Annex XI lists substances with ‘common precursors and/or the likelihood of common breakdown products via physical and biological processes, which result in structurally similar chemicals’, as qualifying for read-across.
Based on the instant hydrolysis of trimethyl borate to release boric acid (see IUCLID section 5.1.2 and analogue approach rationale in section 13), genetic toxicity information from boric acid is taken forward for hazard characterisation.
Short description of key information:
Due to the immediate hydrolysis of trimethyl borate under physiological conditions, data on the hydrolysis product boric acid are applied in the hazard assessment for genotoxicity.
In vitro gene mutation studies in bacteria (Stewart, 1991) in vitro gene mutation studies in mammalian cells (Rudd, 1991) and in vitro cytogenicity studies (NTP, 1987) concluded that boric acid is not genotoxic under the conditions of the studies. In addition the results of an in vivo bone marrow cytogenetic assay (chromosome aberration assay, O’Loughlin 1991) also showed boric acid to be non genotoxic.
Cytotoxicity observed at 5 mg/mL in the in vitro gene mutation studies in mammalian cells (Rudd, 1991).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
No classification is required for trimethyl borate as the hydrolysis product boric acid did not show any potential for genotoxicity in multiple studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
